Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Fillat

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Experimental Neurology|November 6, 2012
Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndromeMaruan Hijazi, Cristina Fillat, José M Medina, et al.
Biochemical Pharmacology|August 30, 2024
The LAMB3-EGFR signaling pathway mediates synergistic Anti-Cancer effects of berberine and emodin in Pancreatic cancerCaiming Xu, Silvia Pascual-Sabater, Cristina Fillat, et al.
Biochimica Et Biophysica Acta|July 6, 2010
Cell cycle control pathways act as conditioning factors for TK/GCV sensitivity in pancreatic cancer cellsDaniel Abate-Daga, Laura Garcia-Rodríguez, Lauro Sumoy, et al.
CNS & Neurological Disorders Drug Targets|June 5, 2010
Insights from mouse models to understand neurodegeneration in Down syndromeCristina Fillat, Mara Dierssen, María Martínez de Lagrán, et al.
Cancers|July 2, 2021
Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer ModelsGiulia Raimondi, Sabrina Gea-Sorlí, Marc Otero-Mateo, et al.
The Journal of Gene Medicine|April 5, 2002
Intratumoral activation of cyclophosphamide by retroviral transfer of the cytochrome P450 2B1 in a pancreatic tumor model. Combination with the HSVtk/GCV systemMeritxell Carrió, Joana Visa, Anna Cascante, et al.
Current Pharmaceutical Design|October 25, 2014
Combining oncolytic virotherapy and cytotoxic therapies to fight cancerCristina Fillat, Maria Victoria Maliandi, Ana Mato-Berciano, et al.
Molecular Cancer Therapeutics|November 6, 2009
Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapyJordi Martinez-Quintanilla, Manel Cascallo, Alena Gros, et al.
Stem Cell Research|October 22, 2013
uPAR-controlled oncolytic adenoviruses eliminate cancer stem cells in human pancreatic tumorsLuciano Sobrevals, Ana Mato-Berciano, Nerea Urtasun, et al.
Microbes and Infection|May 10, 2006
Non-invasive bioluminescence imaging for monitoring herpes simplex virus type 1 hematogenous infectionJavier S Burgos, Fernando Guzman-Sanchez, Isabel Sastre, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Experimental Neurology|November 6, 2012
Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndromeMaruan Hijazi, Cristina Fillat, José M Medina, et al.
Biochemical Pharmacology|August 30, 2024
The LAMB3-EGFR signaling pathway mediates synergistic Anti-Cancer effects of berberine and emodin in Pancreatic cancerCaiming Xu, Silvia Pascual-Sabater, Cristina Fillat, et al.
Biochimica Et Biophysica Acta|July 6, 2010
Cell cycle control pathways act as conditioning factors for TK/GCV sensitivity in pancreatic cancer cellsDaniel Abate-Daga, Laura Garcia-Rodríguez, Lauro Sumoy, et al.
CNS & Neurological Disorders Drug Targets|June 5, 2010
Insights from mouse models to understand neurodegeneration in Down syndromeCristina Fillat, Mara Dierssen, María Martínez de Lagrán, et al.
Cancers|July 2, 2021
Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer ModelsGiulia Raimondi, Sabrina Gea-Sorlí, Marc Otero-Mateo, et al.
The Journal of Gene Medicine|April 5, 2002
Intratumoral activation of cyclophosphamide by retroviral transfer of the cytochrome P450 2B1 in a pancreatic tumor model. Combination with the HSVtk/GCV systemMeritxell Carrió, Joana Visa, Anna Cascante, et al.
Current Pharmaceutical Design|October 25, 2014
Combining oncolytic virotherapy and cytotoxic therapies to fight cancerCristina Fillat, Maria Victoria Maliandi, Ana Mato-Berciano, et al.
Molecular Cancer Therapeutics|November 6, 2009
Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapyJordi Martinez-Quintanilla, Manel Cascallo, Alena Gros, et al.
Stem Cell Research|October 22, 2013
uPAR-controlled oncolytic adenoviruses eliminate cancer stem cells in human pancreatic tumorsLuciano Sobrevals, Ana Mato-Berciano, Nerea Urtasun, et al.
Microbes and Infection|May 10, 2006
Non-invasive bioluminescence imaging for monitoring herpes simplex virus type 1 hematogenous infectionJavier S Burgos, Fernando Guzman-Sanchez, Isabel Sastre, et al.
Pageof 9